Coronary Physiology Systems Global Market Report 2026

The coronary physiology systems market size has grown strongly in recent years. It will grow from $1.34 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing use of invasive diagnostic procedures, adoption of fractional flow reserve (FFR) measurement, expansion of catheterization labs in hospitals, growing demand for accurate hemodynamic assessment.

The coronary physiology systems market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing adoption of integrated physiology and imaging platforms, increasing use of wireless and dual sensor guidewires, rising demand for non-invasive iFR and CFR measurements, expansion of ambulatory surgical centers offering cardiac diagnostics, adoption of AI-enabled data analysis for coronary physiology. Major trends in the forecast period include increasing adoption of wireless pressure guidewires, rising demand for integrated physiology and imaging systems, growing utilization of flow measurement systems for microvascular assessment, expansion of non-invasive coronary physiology modalities, rising focus on real-time data management and analysis software.

The rising incidence of coronary artery disease is propelling the growth of the coronary physiology systems market moving forward. Coronary artery disease is a condition in which the coronary arteries become narrowed or obstructed due to the accumulation of plaque, leading to decreased blood flow and oxygen supply to the heart muscle. The growing occurrence of coronary artery disease is largely attributed to sedentary lifestyles, as limited physical activity contributes to obesity, hypertension, and poor cardiovascular health, thereby increasing the likelihood of plaque buildup in the coronary arteries. Coronary physiology systems assist in diagnosing coronary artery disease by delivering accurate measurements of blood flow and pressure within the coronary arteries, allowing clinicians to precisely evaluate the extent of arterial blockages and make well-informed decisions for targeted treatment. For example, in October 2024, as reported by the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing approximately one-third of all deaths. Coronary heart disease remained the most prevalent type, with nearly one in six cardiovascular-related deaths occurring among adults under 65 years of age. Therefore, the rising prevalence of coronary artery disease is fueling the expansion of the coronary physiology systems market.

Leading companies operating in the coronary physiology systems market are focusing on developing advanced image-based functional assessment solutions to improve procedural efficiency, reduce reliance on invasive pressure wires, and enhance clinical decision-making during coronary interventions. Image-based functional assessment solutions are advanced diagnostic systems that interpret medical imaging data to determine the physiological significance of a condition, enabling functional evaluation without the use of invasive instruments. For example, in April 2025, Medis Medical Imaging Systems, a Netherlands-based medical imaging software company, launched Medis QFR 3 in the United States. The latest image-based functional assessment version enhances workflow automation, delivers improved image processing capabilities, and provides faster and more accurate functional assessment of coronary lesions, supporting interventional cardiologists in optimizing treatment strategies for patients with coronary artery disease.

In December 2024, Terumo Health Outcomes, a US-based healthcare data analytics company, formed a strategic alliance with Medis Medical Imaging to promote precision-focused cardiovascular care through integrated imaging analytics and clinical intelligence. The partnership is intended to strengthen coronary physiology evaluation and interventional decision-making by integrating advanced quantitative imaging software with real-world clinical data and outcomes analytics, thereby enhancing patient results in cardiovascular treatment. Medis Medical Imaging is a Netherlands-based company that specializes in cardiovascular imaging software solutions, including quantitative coronary analysis and physiological assessment technologies utilized in catheterization laboratories.

Major companies operating in the coronary physiology systems market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, HeartFlow Inc., ACIST Medical Systems Inc., Pie Medical Imaging B.V., CathWorks Ltd., Insight Lifetech Co. Ltd., Keya Medical Co. Ltd., Opsens Inc., RADI Medical Systems AB, Medis Medical Imaging Systems B.V., Remedial Life Sciences Pvt. Ltd., Kamal Medtech Pvt. Ltd.

North America was the largest region in the coronary physiology systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary physiology systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary physiology systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary physiology systems market consists of sales of interface modules, hemodynamic recording systems, sensor-tipped guidewires, and calibration devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary physiology systems are sophisticated diagnostic tools used during cardiac catheterization to measure pressure and blood flow in the coronary arteries. They determine whether an arterial narrowing significantly restricts blood supply to the heart muscle, helping cardiologists select the most appropriate treatment, whether interventional or medical, while avoiding unnecessary procedures.

The primary product types of coronary physiology systems include pressure wire systems, flow measurement systems, integrated systems, and other variants. Pressure wire systems are specialized devices used to measure blood pressure and flow within coronary arteries to guide interventional procedures. Modalities include invasive and non-invasive. Applications include fractional flow reserve (FFR), instantaneous wave-free ratio (iFR), coronary flow reserve (CFR), and others, serving hospitals, ambulatory surgical centers, specialty clinics, and other end-users.

Tariffs on imported pressure guidewires, flow measurement devices, and integrated physiology consoles are impacting the coronary physiology systems market by increasing procurement costs, particularly affecting invasive and integrated system segments. Regions such as North America, Europe, and Asia-Pacific, which rely on imported medical devices and components, are most affected. While tariffs increase costs, they also incentivize local manufacturing, promote domestic innovation in physiology and imaging systems, and encourage development of cost-efficient, AI-enabled diagnostic platforms, offering long-term market growth opportunities.

The coronary physiology systems market research report is one of a series of new reports that provides coronary physiology systems market statistics, including coronary physiology systems industry global market size, regional shares, competitors with a coronary physiology systems market share, detailed coronary physiology systems market segments, market trends and opportunities, and any further data you may need to thrive in the coronary physiology systems industry. This coronary physiology systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.